腺素A3受体及其在癌症治疗中的潜在作用:叙述性综述
Joseph V Pergolizzi1, Jo Ann K LeQuang2, Mark H Coleman3
1Pain Management, NEMA Research, Inc., Naples, USA.
Cureus
|November 7, 2025
概括
腺是人体细胞中的关键分子,具有多种代谢作用,并与四种受体 (A1,A2A,A2B,A3) 相互作用. 尽管在瘤进展中具有矛盾的作用,但A3受体激素显示出作为抗癌药物的潜力.
科学领域:
- 生物化学 生物化学
- 细胞生物学 细胞生物学
- 癌症研究 癌症研究
背景情况:
- 氨酸是一种无处不在的纯氨酸核酸,参与细胞代谢和信号传递.
- 它在四个已知的受体上充当全激动剂:A1,A2A,A2B和A3.
- 腺三酸盐 (ATP) 对于能量生产和血管扩张至关重要.
研究的目的:
- 探索腺及其受体在人类细胞功能中的多方面的作用.
- 研究腺受体agonists和antagonists作为抗癌疗法的潜力.
- 了解腺,它的受体和瘤微环境之间的复杂相互作用.
主要方法:
- 审查关于腺代谢和受体信号传递的现有文献.
- 对各种人体组织和癌细胞中腺受体,特别是A3的表达模式的分析.
- 在癌症模型中检查A3受体激动性和对抗性的功能后果.
主要成果:
- 癌细胞和瘤中A3受体的表达很高,作为潜在的生物标志物.
- A3激动剂表现出细胞保护作用,并正在作为抗癌药物进行探索.
- 观察到A3受体活性在瘤进展和转移中的矛盾作用,以及促炎和抗炎作用.
结论:
- 腺素信号传递,特别是通过A3受体,在瘤学中是一个复杂的治疗标.
- 瘤微环境显著影响癌细胞的行为和腺在癌细胞中的作用.
- 需要进一步的研究来阐明向癌症中的腺路径的翻译影响和临床影响.
关键词:
一个a3受体.氨酸 (Adenosine) 是一种氨酸.腺素受体的受体抗癌药物 抗癌药物 抗癌药物癌症细胞生物学癌症细胞生物学细胞保护 细胞保护巨细胞的增殖和扩散.瘤微环境 (TME) 是指瘤的微环境.更多相关视频
11:29HPLC-based Assay to Monitor Extracellular Nucleotide/Nucleoside Metabolism in Human Chronic Lymphocytic Leukemia Cells
Published on: July 20, 2016
11.5K
06:19Author Spotlight: Exploring the Role of Ion Channels in Cancer: Characterization and Potential Treatment Approaches
Published on: June 16, 2023
3.8K
相关概念视频
Adrenergic Receptors: ɑ Subtype
2.6K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
2.6K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
1.4K
α-Adrenergic antagonists, known as α-blockers, exert their effects by inhibiting α-adrenoceptors, leading to specific physiological actions. α1-blockers and α2-blockers have distinct pharmacological actions and therapeutic applications.
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
1.4K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Transducer Mechanism: Enzyme-Linked Receptors
3.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.8K
